The path toward universal access to quality-assured medical products requires a multidisciplinary approach whereby pharmaceutical regulation is not seen (anymore) as a technical issue that is dealt with by technical experts in isolation, but rather as an important component of pharmaceutical systems, that is strictly interconnected to the other systems’ components; and that should benefit from collaboration with policy makers, health economists, social scientists, researchers etc.
In this regard, the recent publication, in the Lancet Global Health, of the Oxford Statement and call to action for global access to quality-assured medical products, is a welcome development.
Meer nieuws over
PUBLIC HEALTH BUITEN LAND